177 related articles for article (PubMed ID: 25085666)
1. Merkel cell carcinoma: current status of targeted and future potential for immunotherapies.
Aldabagh B; Joo J; Yu SS
Semin Cutan Med Surg; 2014 Jun; 33(2):76-82. PubMed ID: 25085666
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.
Becker JC; Stang A; Hausen AZ; Fischer N; DeCaprio JA; Tothill RW; Lyngaa R; Hansen UK; Ritter C; Nghiem P; Bichakjian CK; Ugurel S; Schrama D
Cancer Immunol Immunother; 2018 Mar; 67(3):341-351. PubMed ID: 29188306
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell carcinoma: recent insights and new treatment options.
Schrama D; Ugurel S; Becker JC
Curr Opin Oncol; 2012 Mar; 24(2):141-9. PubMed ID: 22234254
[TBL] [Abstract][Full Text] [Related]
4. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
6. Large nuclear size correlated with better overall survival, Merkel cell polyomavirus positivity, and terminal deoxynucleotidyl transferase expression in Merkel cell carcinoma.
Moran JMT; Biecek P; Donizy P; Wu CL; Kopczynski J; Pieniazek M; Ryś J; Hoang MP
J Am Acad Dermatol; 2021 Feb; 84(2):550-552. PubMed ID: 33317843
[No Abstract] [Full Text] [Related]
7. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
8. Why Merkel Cell Cancer Is Garnering More Attention.
Voelker R
JAMA; 2018 Jul; 320(1):18-20. PubMed ID: 29898204
[No Abstract] [Full Text] [Related]
9. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
Paulson KG; Voillet V; McAfee MS; Hunter DS; Wagener FD; Perdicchio M; Valente WJ; Koelle SJ; Church CD; Vandeven N; Thomas H; Colunga AG; Iyer JG; Yee C; Kulikauskas R; Koelle DM; Pierce RH; Bielas JH; Greenberg PD; Bhatia S; Gottardo R; Nghiem P; Chapuis AG
Nat Commun; 2018 Sep; 9(1):3868. PubMed ID: 30250229
[TBL] [Abstract][Full Text] [Related]
10. Unanswered questions in the management of stage I-III Merkel cell carcinoma.
Zager JS; Messina JL; Glass LF; Sondak VK
J Natl Compr Canc Netw; 2014 Mar; 12(3):425-31; quiz 431. PubMed ID: 24616546
[TBL] [Abstract][Full Text] [Related]
11. Update on the biology and clinical management of Merkel cell carcinoma.
Thakuria M; LeBoeuf NR; Rabinowits G
Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
13. [Merkel cell neoplasm unveiled].
Narusawa H
Gan To Kagaku Ryoho; 2010 Apr; 37(4):634-7. PubMed ID: 20461892
[No Abstract] [Full Text] [Related]
14. The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites.
Ly TY; Walsh NM; Pasternak S
Hum Pathol; 2012 Apr; 43(4):557-66. PubMed ID: 21940035
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
Donepudi S; DeConti RC; Samlowski WE
Semin Oncol; 2012 Apr; 39(2):163-72. PubMed ID: 22484188
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immune targets for Merkel cell carcinoma therapy and prevention.
Cohen L; Tsai KY
Mol Carcinog; 2019 Sep; 58(9):1602-1611. PubMed ID: 31116890
[TBL] [Abstract][Full Text] [Related]
17. Merkel Cell Carcinoma: Current Issues Regarding Diagnosis, Management, and Emerging Treatment Strategies.
Brummer GC; Bowen AR; Bowen GM
Am J Clin Dermatol; 2016 Feb; 17(1):49-62. PubMed ID: 26596990
[TBL] [Abstract][Full Text] [Related]
18. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
Bichakjian CK; Olencki T; Aasi SZ; Alam M; Andersen JS; Blitzblau R; Bowen GM; Contreras CM; Daniels GA; Decker R; Farma JM; Fisher K; Gastman B; Ghosh K; Grekin RC; Grossman K; Ho AL; Lewis KD; Loss M; Lydiatt DD; Messina J; Nehal KS; Nghiem P; Puzanov I; Schmults CD; Shaha AR; Thomas V; Xu YG; Zic JA; Hoffmann KG; Engh AM
J Natl Compr Canc Netw; 2018 Jun; 16(6):742-774. PubMed ID: 29891526
[TBL] [Abstract][Full Text] [Related]
19. [Working Group for Dermatologic Oncology (ADO)].
Becker JC
J Dtsch Dermatol Ges; 2008 Jun; 6(6):525. PubMed ID: 18494721
[No Abstract] [Full Text] [Related]
20. Activation of Protein Kinase C ε in Merkel Cell Polyomavirus-Induced Merkel Cell Carcinoma.
Costa A; Mackelfresh J; Gilbert L; Bonner MY; Arbiser JL
JAMA Dermatol; 2017 Sep; 153(9):931-932. PubMed ID: 28564697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
